Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Cash Equivalents | 19.64 | 0.13 | - | 0.00 |
Short Term Investments | 49.46 | 39.20 | 47.23 | 36.40 |
Cashand Short Term Investments | 69.10 | 59.12 | 57.24 | 48.85 |
Accounts Receivable- Trade Net | 63.22 | 54.31 | 41.43 | 22.94 |
Total Receivables Net | 63.22 | 56.62 | 43.04 | 25.99 |
Total Inventory | 3.99 | 10.40 | 13.66 | 5.39 |
Other Current Assets Total | 9.68 | 0.10 | 0.11 | 0.11 |
Total Current Assets | 145.99 | 126.40 | 114.10 | 80.36 |
Property/ Plant/ Equipment Total- Net | 48.12 | 47.36 | 46.40 | 73.38 |
Intangibles Net | 19.82 | 0.26 | 0.23 | 0.15 |
Long Term Investments | 22.85 | 22.68 | 26.07 | 25.65 |
Note Receivable- Long Term | 0.72 | 0.62 | 0.46 | 0.44 |
Other Long Term Assets Total | 2.56 | 1.98 | 1.51 | 1.28 |
Total Assets | 240.06 | 219.52 | 209.85 | 203.18 |
Accounts Payable | 25.59 | 40.87 | 42.87 | 53.65 |
Notes Payable/ Short Term Debt | 31.65 | 22.19 | 20.43 | 14.80 |
Current Portof LT Debt/ Capital Leases | 0.08 | - | - | - |
Other Currentliabilities Total | 6.90 | 5.81 | 5.97 | 4.86 |
Total Current Liabilities | 64.22 | 68.87 | 69.28 | 73.32 |
Total Debt | 31.72 | 22.19 | 20.43 | 14.80 |
Minority Interest | -0.62 | -1.02 | 1.21 | 2.35 |
Other Liabilities Total | 0.17 | 0.07 | 0.28 | 0.38 |
Total Liabilities | 63.77 | 67.92 | 70.76 | 76.05 |
Common Stock Total | 16.08 | 15.58 | 15.58 | 15.49 |
Retained Earnings( Accumulated Deficit) | 160.21 | 90.82 | 78.19 | 68.33 |
Total Equity | 176.29 | 151.60 | 139.09 | 127.13 |
Total Liabilities Shareholders' Equity | 240.06 | 219.52 | 209.85 | 203.18 |
Total Common Shares Outstanding | 1.61 | 1.56 | 1.56 | 1.55 |
Tangible Book Valueper Share Common Eq | 97.29 | 84.14 | 75.59 | 67.81 |
Cash | - | 19.79 | 10.01 | 12.45 |
Prepaid Expenses | - | 0.16 | 0.05 | 0.03 |
Property/ Plant/ Equipment Total- Gross | - | 72.35 | 68.70 | 94.07 |
Accumulated Depreciation Total | - | -25.00 | -22.30 | -20.69 |
Goodwill Net | - | 20.22 | 21.06 | 21.91 |
Total Long Term Debt | - | 0.00 | 0.00 | 0.00 |
Additional Paid- In Capital | - | 38.33 | 38.33 | 38.33 |
ESOP Debt Guarantee | - | 0.35 | 0.35 | 0.35 |
Other Equity Total | - | 6.51 | 6.63 | 4.63 |
Accrued Expenses | - | - | 0.00 | 0.00 |
Kilitch Drugs India Dividend Kilitch Drugs India Bonus Kilitch Drugs India News Kilitch Drugs India AGM Kilitch Drugs India Rights Kilitch Drugs India Splits Kilitch Drugs India Board Meetings Kilitch Drugs India Key Metrics Kilitch Drugs India Shareholdings Kilitch Drugs India Profit Loss Kilitch Drugs India Cashflow Kilitch Drugs India Q1 Results Kilitch Drugs India Q2 Results Kilitch Drugs India Q3 Results Kilitch Drugs India Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks